Search Within

Alexander Noor Shoushtari

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (28)
  3. Research Letter (5)
  4. Review (1)
Groups
  1. Department of Medicine (67)
  2. Epidemiology and Biostatistics (67)
  3. Hematologic Malignancies, Division of (67)
  4. Melanoma Disease Management Team (67)
  5. Melanoma and Immunotherapeutics Service (67)
  6. Solid Tumor Oncology Division (67)

More Groups

People
  1. Michael Postow (40)
  2. Katherine Panageas (34)
  3. Paul Chapman (32)
  4. Jedd Wolchok (31)
  5. Margaret Callahan (28)
  6. Parisa Momtaz (23)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Clinical Cancer Research (4)
  3. JAMA Oncology (4)
  4. Annals of Surgical Oncology (3)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (6)
  4. Springer (6)
  5. American Medical Association (4)
  6. Elsevier Inc. (4)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: Mutational signature analysis and immunotherapy response
    Journal Article

    Kasago, I. S.; Chatila, W. K.; Lezcano, C. M.; Febres-Aldana, C. A.; Schultz, N.; Vanderbilt, C.; Dogan, S.; Bartlett, E. K.; D'Angelo, S. P.; Tap, W. D.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Examining the impact of chromosomal instability on mucosal melanoma tumor infiltrate and responses to PD-1 based therapy
    Meeting Abstract

    Armstrong, E.; Gottesdiener, L.; Schultz, N.; Bakhoum, S. F.; Hollmann, T. J.; Shoushtari, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Urethral melanoma - Clinical, pathological and molecular characteristics
    Review

    Mano, R.; Hoeh, B.; DiNatale, R. G.; Sanchez, A.; Benfante, N. E.; Reznik, E.; Leitao, M. M.; Shoushtari, A. N.; Goh, A.; Donat, S. M.; more...
    Bladder Cancer (2022)

    Fulltext@MSK | Save
  • Association between toxic effects and survival in patients with cancer and autoimmune disease treated with checkpoint inhibitor immunotherapy
    Research Letter

    Han, C. Y.; Fitzgerald, C.; Lee, M.; Valero, C.; Gönen, M.; Shoushtari, A.; Morris, L. G. T.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Adaptive dosing of nivolumab + ipilimumab immunotherapy based upon early, interim radiographic assessment in advanced melanoma (The ADAPT-IT study)
    Journal Article

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; Smithy, J. W.; Naito, E.; Cugliari, M. K.; Raber, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save